TRANSITION SERVICES AGREEMENT BETWEEN INHIBRX BIOSCIENCES, INC. AND INHIBRX, INC. DATED MAY 29, 2024Transition Services Agreement • May 30th, 2024 • Inhibrx Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 30th, 2024 Company Industry JurisdictionThis TRANSITION SERVICES AGREEMENT, dated May 29, 2024 (as amended, modified or supplemented from time to time in accordance with its terms, this “Agreement”), is made and entered into by and between Inhibrx, Inc., a Delaware corporation (“RemainCo”), and Inhibrx Biosciences, Inc., a Delaware corporation (“SpinCo”). Unless otherwise defined herein, all capitalized terms used herein shall have the same meanings as in the Separation Agreement (as defined below).
TRANSITION SERVICES AGREEMENT BETWEEN INHIBRX BIOSCIENCES, INC. AND INHIBRX, INC. DATED [●], 2024Transition Services Agreement • March 4th, 2024 • Inhibrx Biosciences, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 4th, 2024 Company Industry JurisdictionThis TRANSITION SERVICES AGREEMENT, dated [●], 2024 (as amended, modified or supplemented from time to time in accordance with its terms, this “Agreement”), is made and entered into by and between Inhibrx, Inc., a Delaware corporation (“RemainCo”), and Inhibrx Biosciences, Inc., a Delaware corporation (“SpinCo”). Unless otherwise defined herein, all capitalized terms used herein shall have the same meanings as in the Separation Agreement (as defined below).